BPC 157 Dosing (Common Protocols), Oral Subcutaneous, 500 mcg daily, Duration: 6 weeks, Intramuscular Peritendinous, 1 mg daily, Duration: 6 weeks, Note:, Not approved by FDA or BPC 157 Benefits, Dosage & Before After Results Stable Gastric Pentadecapeptide BPC 157 Therapy for Monocrotaline Induced Pulmonary Hypertension in Rats Leads to Prevention and Reversal JPP No 5 2013 article 09 Liposomal BPC 157+TB 500, Quicksilver Scientific Natural Healthy Concepts Bpc 157 and TB 500 My protocol and results explained! I've talked about this with probably a dozen different guys over the last 4 months so hopefully this helps someone else. #progress #